Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides

NCT02261467 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT02261467
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02261467 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Forehead and Glabellar Facial Rhytides
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
October 21, 2014
Completion date
April 26, 2016
Enrollment
421 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

forehead rhytides, glabellar rhytides